Sequence Bio is a gene therapy company founded in 2018 and headquartered in San Francisco, California. The company develops treatments for monogenic genetic diseases, which are conditions caused by mutations in a single gene. Operating as a private, venture-backed biotechnology firm, Sequence Bio applies modern gene therapy approaches to address the significant unmet medical needs in the genetic disease space. The company's focus on single-gene disorders positions it in the growing field of precision medicine and genetic therapeutics.
2 open now, 2 first appeared in the last 30d.
No open roles right now.